Cargando…
Lactobacillus johnsonii N6.2 Mitigates the Development of Type 1 Diabetes in BB-DP Rats
BACKGROUND: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal barrier function and aberrant mucosal immune activation...
Autores principales: | Valladares, Ricardo, Sankar, Dhyana, Li, Nan, Williams, Emily, Lai, Kin-Kwan, Abdelgeliel, Asmaa Sayed, Gonzalez, Claudio F., Wasserfall, Clive H., Larkin, Joseph, Schatz, Desmond, Atkinson, Mark A., Triplett, Eric W., Neu, Josef, Lorca, Graciela L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865539/ https://www.ncbi.nlm.nih.gov/pubmed/20463897 http://dx.doi.org/10.1371/journal.pone.0010507 |
Ejemplares similares
-
Complete Genome Sequences of Lactobacillus johnsonii Strain N6.2 and Lactobacillus reuteri Strain TD1
por: Leonard, Michael T., et al.
Publicado: (2014) -
Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults
por: Marcial, Guillermo E., et al.
Publicado: (2017) -
Identification of Biomarkers for Systemic Distribution of Nanovesicles From Lactobacillus johnsonii N6.2
por: Harrison, Natalie A., et al.
Publicado: (2021) -
Lactobacillus johnsonii N6.2 phospholipids induce immature-like dendritic cells with a migratory-regulatory-like transcriptional signature
por: Cuaycal, Alexandra E., et al.
Publicado: (2023) -
Nanovesicles From Lactobacillus johnsonii N6.2 Reduce Apoptosis in Human Beta Cells by Promoting AHR Translocation and IL10 Secretion
por: Teixeira, Leandro D., et al.
Publicado: (2022)